| 28.72 Data as of May 10 |  +0.12 / +0.42%Today’s Change | 21.40 Today|||52-Week Range 31.15 | +14.52% Year-to-Date |
| 5 Huge Stocks to Trade: Must-See Charts May 09 / TheStreet.com | Pfizer Stock To Go Ex-dividend Tomorrow (PFE) May 07 / TheStreet.com |
| Narrower Loss from Onyx, Guidance Maintained - Analyst Blog May 08 / Zacks.com | Redx Pharma moves to AstraZeneca R&D site in Cheshire May 06 / FT.com |
| Trius Therapeutics Remains One Of Our Best Ideas - Analyst Blog May 08 / Zacks.com | Dow Today: Pfizer (PFE) Lower May 06 / TheStreet.com |
| 5 Stocks Advancing The Drugs Industry May 07 / TheStreet.com | Pfizer to start selling Viagra online May 06 / CNNMoney.com |
| Merck's Liptruzet Approved in the US - Analyst Blog May 07 / Zacks.com | Shire - rarity value May 03 / FT.com |
| Previous close | 28.60 |
| Today’s open | 28.59 |
| Day’s range | 28.57 - 28.80 |
| Volume | 33,069,918 |
| Average volume (3 months) | 31,641,636 |
| Market cap | $205.5B |
| Dividend yield | 3.34% |
| Earnings growth (last year) | +17.43% |
| Earnings growth (this year) | +1.81% |
| Earnings growth (next 5 years) | +4.00% |
| Revenue growth (last year) | -12.52% |
| P/E ratio | 20.4 |
| Price/Sales | 3.16 |
| Price/Book | 2.56 |
| Today’s change | Today’s % change | |
|---|---|---|
| NVSNovartis AG | +0.72 | +0.97% |
| JNJJohnson & Johnson | +0.61 | +0.72% |
| SNYSanofi SA | +0.66 | +1.22% |
| MRKMerck & Co Inc | +0.46 | +1.01% |
| Next reporting date | July 24, 2013 |
| EPS forecast (this quarter) | $0.58 |
| Annual revenue (last year) | $59.0B |
| Annual profit (last year) | $9.8B |
| Net profit margin | 16.09% |
Sector Health Technology |
Industry Pharmaceuticals: Major |
Chairman & Chief Executive Officer Ian C. Read |
President & General Manager-Emerging Markets Olivier Brandicourt, PhD, MD |
Corporate headquarters New York, New York |
.
